| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/06/04 | 05 : 15 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/06/01 | 05 : 30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/06/01 | 05 : 23 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/06/01 | 05 : 21 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/31 | 05 : 15 | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/29 | 22 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/20 | 22 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/15 | 05 : 15 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/14 | 05 : 30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/14 | 05 : 15 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/14 | 05 : 05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/10 | 22 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024 | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/10 | 05 : 31 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/09 | 05 : 56 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/07 | 11 : 15 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/06 | 22 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®) | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/04/24 | 22 : 05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/04/03 | 20 : 05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™ | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/03/29 | 05 : 05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/03/15 | 20 : 05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/03/12 | 21 : 59 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/03/07 | 21 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/03/04 | 21 : 30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/03/04 | 21 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/02/14 | 09 : 09 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/02/10 | 06 : 15 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/02/07 | 00 : 22 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/02/06 | 21 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/02/05 | 21 : 05 | GlobeNewswire Inc. | Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/01/11 | 21 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital | NASDAQ:HSDT | Helius Medical Technologies Inc |